Joshua Barney

With a little tweak of the color palette, UVA researchers have made it easier for scientists to unravel the mysteries of disease and develop new treatments.

Nearly 1 in 8 commercially insured patients nationwide who underwent an elective colonoscopy between 2012 and 2017 performed by an in-network provider received “surprise” bills for out-of-network expenses, often totaling hundreds of dollars or more, a new analysis shows.

UVA Health is testing the antibody cocktail to determine if it can prevent COVID-19 infection in people who share a household with someone with the illness.

Ambitious efforts at UVA Cancer Center to improve care for patients with cancer that has spread to the brain have yielded important insights and tools that can benefit other hospitals.

UVA is exploring the potential of “low-intensity shockwave therapy” to address erectile dysfunction by promoting blood vessel growth and tissue repair.

New findings about fat help explain the differing health risks men and women face – and set the stage for better, more targeted treatments.

A commentary highlights how new COVID-19 findings have important implications for the development of vaccines and immune therapies for the disease.

Patients taking drugs called NRTIs to treat HIV and hepatitis B had a 33% lower risk of developing diabetes.

A consortium of 17 cancer centers in the United States, including UVA Cancer Center, have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.

A new discovery from the School of Medicine may open the door to a new approach to treating cancer: by disrupting a vital condensation process inside cancer cells.